Trade idea. Choppy. Pay close attention to RSI and MAC D histo. Price targets in blue upon validation.
First Half 2014: Initiate Phase II efficacy trial in spinal cord treatment
2014: Initiate Phase II efficacy trial in AMD
2015: Interim results of proof of concept trials on both AMD and spinal cord injuries
2016: The company plans to file an IND for the safety and efficacy of HuCNS-SC cells to restore memory loss in Alzheimer's patients.
First Half 2014: Initiate Phase II efficacy trial in spinal cord treatment
2014: Initiate Phase II efficacy trial in AMD
2015: Interim results of proof of concept trials on both AMD and spinal cord injuries
2016: The company plans to file an IND for the safety and efficacy of HuCNS-SC cells to restore memory loss in Alzheimer's patients.